Concord Drugs share news, announcements and annual reports
BSE: 538965Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹65.99.
30 Oct: open ₹65.99, high ₹65.99, low ₹63.03
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹84 Cr3,001st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 40.81
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 5.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 7.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.28
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 1,732
Concord Drugs has 433 announcements on record, routine notices left out; none in the 30 days to 1 Nov 2026, the latest on 1 Oct 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Concord Drugs quarterly results
The board met on 10 Aug 2026 to consider quarterly results
Notice filed 3 Aug 2026
Concord Drugs annual reports, presentations and earnings calls
The company's own documents, latest first.Concord Drugs financials, year by year
Annual reports14
- Annual report, year to Mar 20267 Sep 2026
- Annual report, year to Mar 20259 Sep 2025
- Annual report, year to Mar 20246 Sep 2024
- Annual report, year to Mar 20238 Sep 2023
- Annual report, year to Mar 20228 Sep 2022
9 earlier reports
- Annual report, year to Mar 20218 Sep 2021
- Annual report, year to Mar 20207 Dec 2020
- Annual report, year to Mar 20196 Sep 2019
- Annual report, year to Mar 201817 Oct 2018
- Annual report, year to Mar 201729 Sep 2017
- Annual report, year to Mar 201615 Oct 2016
- Annual report, year to Mar 2014Filing day not known
- Annual report, year to Mar 2013Filing day not known
- Annual report, year to Mar 2012Filing day not known
Concord Drugs share news and announcements
Newest first. Page 1 of 9.
Oct 2026
1 Oct · Meeting
Sep 2026
30 Sep · Meeting
7 Sep · Letter To Shareholders
7 Sep · Meeting
7 Sep · Meeting
7 Sep · Meeting
7 Sep · Board meeting
Aug 2026
10 Aug · Results
3 Aug · Board meeting
Meeting on 10 Aug 2026: quarterly results
May 2026
29 May · Results
18 May · Board meeting
Meeting on 27 May 2026: audited results
Apr 2026
10 Apr · Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Feb 2026
16 Feb
14 Feb · Announcement under Regulation 30 (LODR)-Retirement
2 Feb · Board meeting
Meeting on 14 Feb 2026: quarterly results
Dec 2025
Nov 2025
24 Nov · Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
20 Nov · Board meeting
20 Nov · Announcement under Regulation 30 (LODR)-Allotment
13 Nov · Results
4 Nov · Board meeting
Meeting on 13 Nov 2025: quarterly results
Oct 2025
1 Oct · Meeting
Sep 2025
30 Sep · Meeting
8 Sep · Letter To Shareholders
8 Sep · Annual Report
8 Sep · Meeting
8 Sep · Meeting
8 Sep · Management
8 Sep · Board meeting
Aug 2025
8 Aug · Results
1 Aug · Board meeting
Meeting on 8 Aug 2025: quarterly results1 Aug · Meeting
Jul 2025
31 Jul · Meeting
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.
- 30 Dec 2025Order receivedup 3.44%+3.5 pts vs Nifty 500market median +1.1% · five sessions +1.7% (+0.1 pts vs Nifty 500) · volume 9.7× usual · The announcement
- 9 Sep 2025Board or managers changedup 2.00%+1.7 pts vs Nifty 500market median 0.0% · five sessions +4.5% (+3.1 pts vs Nifty 500) · volume 1.1× usual · The announcement
- 10 Apr 2023Board or managers changedup 0.24%0.0 pts vs Nifty 500market median 0.0% · five sessions +5.9% (+4.9 pts vs Nifty 500) · volume 2.3× usual · The announcement
- 11 Nov 2022Board or managers changedup 0.15%−1.2 pts vs Nifty 500market median 0.0% · five sessions −5.0% (−6.0 pts vs Nifty 500) · volume 0.7× usual · The announcement
- 2 Jun 2022Board or managers changeddown 3.45%−4.1 pts vs Nifty 500market median 0.0% · five sessions −5.6% (−4.2 pts vs Nifty 500) · volume 1.3× usual · The announcement
- 9 May 2022Board or managers changedup 1.25%+2.3 pts vs Nifty 500market median 0.0% · five sessions 0.0% (+4.8 pts vs Nifty 500) · volume 0.2× usual · The announcement
- 18 Apr 2019Board or managers changedup 4.58%+5.0 pts vs Nifty 500market median 0.0% · five sessions +5.0% (+6.6 pts vs Nifty 500) · volume 1.5× usual · The announcement
- 23 May 2018Board or managers changedup 1.14%+2.0 pts vs Nifty 500market median 0.0% · five sessions −3.2% (−4.6 pts vs Nifty 500) · volume 0.5× usual · The announcement
Figures filed again
Lines the company later filed with a different value, rupee lines in ₹ crore and per-share lines in rupees.
| Line | Period | Accounts | First filed | Filed again | Change. The value filed again less the value first filed, as a per cent of the first. | First filed on | Filed again on |
|---|---|---|---|---|---|---|---|
| Materials used | Year to date to Sep 2025 | Standalone | 18.49 | 18.36 | −0.7% | 13 Nov 2025 | 14 Feb 2026 |
| Total expenses | Year to date to Sep 2025 | Standalone | 23.17 | 23.04 | −0.6% | 13 Nov 2025 | 14 Feb 2026 |
| Profit before tax | Year to date to Sep 2025 | Standalone | 0.29 | 0.42 | +47.2% | 13 Nov 2025 | 14 Feb 2026 |
| Tax | Year to date to Sep 2025 | Standalone | 0.08 | 0.12 | +43.5% | 13 Nov 2025 | 14 Feb 2026 |
| Net profit | Year to date to Sep 2025 | Standalone | 0.21 | 0.31 | +48.6% | 13 Nov 2025 | 14 Feb 2026 |
| Profit before one-off items and tax | Year to date to Sep 2025 | Standalone | 0.29 | 0.42 | +47.2% | 13 Nov 2025 | 14 Feb 2026 |
| Current tax | Year to date to Sep 2025 | Standalone | 0.09 | 0.13 | +37.2% | 13 Nov 2025 | 14 Feb 2026 |
| Net profit from continuing businesses | Year to date to Sep 2025 | Standalone | 0.21 | 0.31 | +48.6% | 13 Nov 2025 | 14 Feb 2026 |
| Total comprehensive income | Year to date to Sep 2025 | Standalone | 0.21 | 0.31 | +48.6% | 13 Nov 2025 | 14 Feb 2026 |